572 search results for “bart cancer metastasis” in the Staff website
-
Leiden joins EU effort to unite Europe’s cancer research networks
The more data from cancer research we pool, the better we can search for new treatments. But how can we keep patient data safe when sharing it? Leiden researchers will tackle this challenge in a major European project.
-
Bart de Smit reappointed as vice-dean at Leiden Science
The Executive Board has reappointed Professor of Algebra and Number Theory Bart de Smit as vice-dean at the Faculty of Science. De Smit had already held this position since the beginning of 2019. His term has been extended by four years until the end of 2026.
-
impact does communication have on individuals dealing with advanced cancer? Looking for participants
This study is important because it seeks to uncover whether clinicians' communication influences neurobiological and physiological outcomes for patients.
-
Bart Custers in De Jurist on UBO register and privacy legislation
Ultimate beneficial owners (UBOs) of companies should have registered their information in the Dutch UBO register before 27 March 2022. The Dutch Minister of Finance saw no reason to postpone the deadline for registration, according to answers to parliamentary questions. In an article on the legal platform…
-
Rietveld Award for innovative research on blood donation and colorectal cancer
One used 3D cell models to study colorectal cancer, while the other used machine learning for more efficient blood donation. For these achievements, Marieke Vinkenoog and Simon Christian Hansmann were awarded the Krijn Rietveld Memorial Innovation Award on Tuesday 2 September.
-
Sylvestre BonnetFaculty of Science
bonnet@chem.leidenuniv.nl | +31 71 527 4260
-
National Growth Fund invests many millions in faster and more sustainable (cancer) drug development
On 14 April, the National Growth Fund awarded million euros in grants to two consortia in which Leiden's science faculty is involved. Pharma-NL will receive 80 million euros and Oncode-PACT 325 million euros. Pharma-NL wants to make medicines available to the patient faster and more sustainably. Oncode-PACT…
-
Stiffness and viscosity of cells differ in cancer and other diseases
During illness, the stiffness or viscosity of cells can change. Tom Evers demonstrated this by measuring such properties of human immune cells for the first time. ‘The stiffness of certain cells could be a way to make a diagnosis,’ Evers said. He defended his thesis on March 26th.
-
Alumnus Bart Jansen: ‘It’s up to us legal philosophers to make sense of these times’
Legal philosopher Bart Jansen teaches at universities around the world. In an interview two years ago, he spoke about his professional fascination for dictators and wars. Since then, the world has undergone major changes. High time for a follow-up interview.
-
Alumnus, rechtsfilosoof en wereldreiziger Bart Jansen: ‘focus je niet, maar verstrooi jezelf’
Stilzitten doet alumnus Bart Jansen niet graag. Zo geeft hij les in onder meer Nederland, Maleisië en Curaçao, houdt hij zich naast het recht ook graag bezig met kunst en mystiek en vindt hij naar eigen zeggen ‘alles wat fout gaat’ wel interessant aan de rechtsfilosofie. ‘Ik ben gek op veelzijdige mensen;…
-
Zuijderveldt won first prize in the ‘Schild-De Groen Onderzoeksprijzen' for cancer research
One of our PhD candidates at the LACDR, Joey Zuijdervelt, recently achieved recognition by winning the first prize in the ‘Schild-De Groen Onderzoeksprijzen’ for cancer research. His award-winning master’s thesis explored glioblastoma multiforme through an innovative orthotopic zebrafish xenograft model,…
-
Margo DonaFaculty of Science
m.a.dona@umail.leidenuniv.nl | 071 5272727
-
receives ERC Proof of Concept grant for MYSTIC, to advance an innovative cancer treatment idea
Sebastian Pomplun from the Leiden Academic Centre for Drug Research has recently received an ERC Proof of Concept grant for his ambitious MYSTIC project. This initiative is set to transform cancer treatment by advancing the development of HeloMYC, a pioneering therapeutic candidate designed to target…
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Bart Barendregt receives Vici grant for research on Artificial Intelligence in Muslim Southeast Asia
Bart Barendregt receives a Vici grant of 1.5 million euros from the NWO for his research project 'One between the Zeros, an Anthropology of Artificial Intelligence in Islam'.
-
Contributing to cancer research in your own way: three PhD candidates on their work within Oncode Accelerator
Accelerating the development of new cancer medicines by joining forces—that’s the mission of Oncode Accelerator, a Dutch consortium that recently welcomed three Leiden-based PhD candidates. Under the guidance of Gerard van Westen, Marc Boef, Remco van den Broek, and Lucina-May Nollen are exploring how…
-
Bart Custers and Eduard Fosch-Villaronga examine the legal and ethical aspects of AI in radiology
Researchers at eLaw contribute to groundbreaking volume on AI in radiology, offering legal and ethical frameworks, governance models, and solutions for responsible clinical integration.
-
Dutch Cancer Society allocates funds to a mathematician: for treating Ewing sarcoma with the help of an app
If doctors could better estimate a patient's chances of survival, this would help in choosing a specific treatment. It would be particularly beneficial for the rare and malignant Ewing sarcoma, which mainly affects children and adolescents. Mathematics professor Marta Fiocco has been awarded a substantial…
-
Zware metalen hebben slechte reputatie, maar genezen ook kanker
Veel mensen denken dat zware metalen giftig zijn en mens en natuur altijd schade aanbrengen. Dat beeld moet genuanceerd worden, vindt hoogleraar Sylvestre Bonnet.
-
Lioe-Fee de Geus-OeiFaculteit Geneeskunde
l.f.de_geus-oei@lumc.nl | +31 71 526 9111
-
Nederlandse bedrijven naar online prijsdiscriminatie? Kimia Heidary, Bart Custers, Helen Pluut en Jean-Pierre van der Rest schreven hier een artikel
Hoe kijken Nederlandse bedrijven naar online prijsdiscriminatie? Kimia Heidary, Bart Custers, Helen Pluut en Jean-Pierre van der Rest schreven hier een artikel over.
-
Regulation of signal transduction pathways by hypoxia in breast cancer subtypes
PhD defence
-
Erik DanenFaculty of Science
e.danen@lacdr.leidenuniv.nl | +31 71 527 4486
-
Peter BouwmanFaculty of Science
r.j.p.bouwman@lacdr.leidenuniv.nl | 071 5276105
-
Zebrafish against cancer
Valedictory lecture
-
'There's nothing more we can do for you' - New publication on harmful communication in oncology
PhD student Janine Westendorp and her colleagues conducted literature research on what patients with cancer and their loved ones perceive as harmful communication from healthcare providers. The results were published in the journal Psycho-Oncology and are released as a poster to distribute to healthcare…
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
Eleven Open Competition Domain Science XS grants for Leiden researchers
Eleven researchers from Leiden University have been awarded an Open Competition Domain Science ENW XS grant by the Dutch Research Council for their research projects. They are researching how to make software faster and greener, improve cancer detection and reduce anxiety by manipulating the biological…
-
Interview Klara Beslmüller
Klara Beslmüller
-
How to develop cancer drugs with less side effects
Lecture, Tuesday Talks: Science Insights
-
Hadassah DrukarchFaculty of Law
h.g.drukarch@law.leidenuniv.nl | 071 5272727
-
Nature Communications paper on therapeutic melanoma inhibition by local micelle-mediated cyclic nucleotide repression
Cancer immunotherapy represents a significant breakthrough in cancer treatment. However, tumors have numerous mechanisms by which they evade destruction by the immune system. It is therefore necessary to decipher and reverse these mechanisms in order to improve immunotherapies.
-
Elizabeth (Liesbeth) de LangeFaculty of Science
ecmdelange@lacdr.leidenuniv.nl | +31 71 527 6330
-
Teachers' tips
How do you teach? Every teacher has their own style, and often an arsenal of tricks, lessons learned and insights. In every Education Newsletter, a teacher shares a personal tip. Here's an overview.
-
Contact
The TEC project team is driving this together with the faculty implementation teams. The implementation coordinator for your faculty or institute (see below) will keep you up to date with developments. They are also your contact person for questions.
-
SSH-labs Support
Staff from the Faculty of Social and Behavioural Sciences and the Faculty of Humanities jointly provide lab support to the participating institutes.
-
‘Using real-world data to enhance our healthcare system’
On 16 May 2022, Professor Michel Wouters from the Department of Biomedical Data Sciences at the Leiden University Medical Centre (LUMC), will deliver his inaugural lecture titled ‘Quality of Cancer Care: why the real world matters’. Wouters will use the opportunity to describe how quality registries…
-
John HaanenFaculteit Geneeskunde
j.haanen@nki.nl | +31 71 526 3057
-
Rick HaasFaculteit Geneeskunde
r.l.m.haas@lumc.nl | +31 71 526 9111
-
Eveline BleikerFaculteit Geneeskunde
e.bleiker@nki.nl | +31 71 526 8033
-
Patient-derived models of breast cancer: A breakthrough story of the duct
PhD defence
-
Disrupting the transcriptional machinery to combat triple-negative breast cancer
PhD defence
-
BRCA1-associated breast cancer: finding new weapons for an old villain
PhD defence
-
Multifaceted Roles of Grainyhead-like Transcription Factor- 2 in Breast Cancer
PhD defence
-
Mini organs-on-chips: an alternative to drug testing on animals
Mini organs-on-chips allow us to study how diseases develop and how drugs work. Although the technology is not new, it is becoming increasingly advanced. PhD candidate Bart Kramer hopes it will eliminate animal testing in the future.
-
James HardwickFaculteit Geneeskunde
j.c.h.hardwick@lumc.nl | +31 71 526 5364
-
Maarten VermeerFaculteit Geneeskunde
m.h.vermeer@lumc.nl | +31 71 526 1952
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'
'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…
-
Life after the Grand Jamboree: Wrapping-up iGEM
‘A challenging rollercoaster, but also a very bonding and insightful experience,’ that’s how the team of iGEM Leiden 2022 wraps up their participation in the iGEM contest. The contest for synthetic biology climaxed during the Grand Jamboree in Paris. The team ended up in the top 10 of over 360 teams…
-
Grants for fundamental research in Leiden
Three fundamental research projects at Leiden in physics, chemistry and medical science have received funding from the Dutch Research Council (NWO). They involve research on magnetic fields in the universe, the role of myeloid cells in cancer immunotherapy and the evolution of ancient proteins.